FDA To Yank Marketing Approval For Menaflex Device

Law360, New York (October 14, 2010, 7:20 PM EDT) -- The U.S. Food and Drug Administration revealed Thursday that it is planning to rescind its erroneous marketing clearance for a ReGen Biologics Inc. knee device, following the release of a report finding that the approval was compromised by Capitol Hill pressure and a lack of safety data.

ReGen's Menaflex Collagen Scaffold device should never have been cleared by the FDA in December 2008 for the repair and reinforcement of the meniscal tissue in the knee, the regulator admitted in a press release.

The agency reached this...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.